Search

Melinda L Verdone

from Monona, WI
Age ~48
Get Report
Also known as:
Melinda C Verdone, Melinda L Eddy, Eddy L Melinda
Related to:
Anita Reddy Winey, 58Joseph VerdonePrashanth Reddy, 52Jayaprakash Reddy, 47Pramila Reddy, 84
Connected to:
Charles P Verdone, 45Tami L Verdone, 58Anthony G Verdoni, 38David A Verdonk, 50Emily A Verdonk, 33Michael Verdonk, 42Marcel E Verdoodt, 102Megan B Verdoorn, 43Rachel L Verdoorn, 53Robert L Verdoorn, 51

Melinda Verdone Phones & Addresses

  • Monona, WI
  • Park Falls, WI
  • Wheaton, IL
  • North Aurora, IL
  • Aurora, IL
  • Kirkland, IL
  • Hoffman Estates, IL
  • Waunakee, WI
  • Sun Prairie, WI
  • Dane, WI

Resumes

Resumes

Melinda Verdone Photo 1

Program Manager, Ms In Applied Biotechnology

View page
Location:
Wheaton, IL
Industry:
Higher Education
Work:
Midwestern University Nov 2015 - Apr 2019
Senior Education Specialist, Chicago College of Pharmacy
University of Wisconsin Extended Campus Nov 2015 - Apr 2019
Program Manager, Ms In Applied Biotechnology
Rock Valley College Aug 2012 - Nov 2015
Faculty, Tenured
Stablebody Technologies, Llc Mar 2011 - Aug 2012
Lab Manager
Mithridion Jan 2007 - Nov 2010
Senior Research Scientist
Education:
Edgewood College 2017 - 2019
Doctorates, Doctor of Education, Education Edgewood College 2012 - 2014
Masters, Master of Arts, Teaching, Education Northern Illinois University 1997 - 1999
Master of Science, Masters, Microbiology, Immunology Western Illinois University 1995 - 1997
Bachelors, Bachelor of Science, Biology College of Dupage 1993 - 1995
Associates, Biology
Skills:
R&D
Molecular Biology
Lifesciences
Life Sciences
Biotechnology
Biochemistry
Research
Protein Chemistry
Teaching
Elisa
Western Blotting
Protein Purification
Drug Discovery
Science
Pcr
Cell Culture
Higher Education
Protein Expression
Working With Students
Dna
Therapeutics
Diagnostics
Purification
Glp
Antibodies
Biopharmaceuticals
Microbiology
Cell Biology
Assay Development
Pharmaceutical Industry
High Performance Liquid Chromatography
Certifications:
Initial Education Licensure, Ea-A, Broadfield Science & Biology
Professional Educator License, Secondary Education, Biology
Melinda Verdone Photo 2

Melinda Verdone

View page
Location:
Madison, WI

Publications

Us Patents

Method Of Inducing Nucleation Of A Material

View page
US Patent:
20070186567, Aug 16, 2007
Filed:
Feb 5, 2007
Appl. No.:
11/702472
Inventors:
Theodore Hall Gasteyer - Naperville IL, US
Robert Rex Sever - Arlington Heights IL, US
Balazs Hunek - Chicago IL, US
Nigel Grinter - Buffato Grove IL, US
Melinda Lee Verdone - Hoffman Estates IL, US
International Classification:
F25C 1/00
US Classification:
62 66
Abstract:
Methods of inducing nucleation of a material is provided. The disclosed methods comprise the steps of bringing the material to a temperature near or below a phase transition temperature and altering the pressure to induce nucleation of the material. The disclosed methods are useful in freeze-drying processes, particularly pharmaceutical freeze-drying processes.

Compounds And Compositions For Cognition-Enhancement, Methods Of Making, And Methods Of Treating

View page
US Patent:
20110263613, Oct 27, 2011
Filed:
Jan 11, 2011
Appl. No.:
13/004877
Inventors:
Michael L. Hendrickson - Madison WI, US
Jeffrey C. Ockuly - Madison WI, US
Trevor M. Twose - Fitchburg WI, US
Melinda L. Verdone - Waunakee WI, US
Brent D. Abraham - Verona WI, US
Richard R. Copp - Oregon WI, US
James G. Farnham - Madison WI, US
Seth A. Hanson - Madison WI, US
International Classification:
A61K 31/506
A61K 31/438
A61P 25/18
A61K 31/4245
A61P 25/04
A61P 25/28
C07D 413/04
A61K 31/454
US Classification:
514256, 546112, 514299, 546209, 514326, 548131, 514364, 544333
Abstract:
Disclosed are muscarinic agonist compounds including oxadiazole derivatives, compositions and preparations thereof. Also disclosed are methods of synthesizing such oxadiazole compounds. Further disclosed are methods for treating a subject with said muscarinic agonists or a pharmaceutically suitable form thereof to enhance cognitive function.

Compounds And Compositions For Cognition-Enhancement, Methods Of Making, And Methods Of Treating

View page
US Patent:
20120046273, Feb 23, 2012
Filed:
Mar 5, 2010
Appl. No.:
13/255096
Inventors:
Trevor M. Twose - Fitchburg WI, US
Brent D. Abraham - Verona WI, US
Richard R. Copp - Oregon WI, US
James G. Farnham - Madison WI, US
Seth A. Hanson - Madison WI, US
Michael L. Hendrickson - Madison WI, US
Jeffrey C. Ockuly - Madison WI, US
Melinda L. Verdone - Waunakee WI, US
Assignee:
MITHRIDION, INC. - MADISON WI
International Classification:
A61K 31/55
C07D 417/04
A61P 25/28
A61K 31/4439
A61K 31/4245
A61K 31/433
C07D 413/04
A61K 31/506
US Classification:
5142171, 544333, 548131, 5462694, 5462687, 540603, 514256, 514340, 514342, 548128, 514364, 514361
Abstract:
Muscarinic agonists, which are useful for stimulating muscarinic receptors and treating cognitive disorders, are provided. Methods of synthesizing such agonists also are provided. Also provided are compositions for enhancing cognitive function in subjects such as humans, the compositions comprising a muscarinic agonist or a pharmaceutically suitable form thereof. Also provided are methods of treating animals such as humans by administering such compositions.

Cognition Enhancing Compounds And Compositions, Methods Of Making, And Methods Of Treating

View page
US Patent:
20130274299, Oct 17, 2013
Filed:
Mar 8, 2013
Appl. No.:
13/791251
Inventors:
Richard R. Copp - Oregon WI, US
James G. Farnham - Madison WI, US
Seth A. Hanson - Madison WI, US
Michael L. Hendrickson - Madison WI, US
Jeffrey C. Ockuly - Madison WI, US
Trevor M. Twose - Fitchburg WI, US
Melinda L. Verdone - Waunakee WI, US
International Classification:
C07D 413/04
US Classification:
514364, 548131
Abstract:
The invention relates generally to muscarinic agonists, which are useful for stimulating muscarine receptors, and treating cognitive disorders. Included among the muscarinic agonists disclosed herein are oxadiazole derivatives, compositions, and preparations thereof. Methods of synthesizing oxadiazole compounds also are provided. This disclosure also relates in part to compositions for enhancing cognitive function in subjects such as humans, the compositions comprising a muscarinic agonist or a pharmaceutically suitable form thereof. This disclosure relates in part to methods of treating animals such as humans by administering such compositions.

Lyophilization System And Method

View page
US Patent:
20070186437, Aug 16, 2007
Filed:
Feb 5, 2007
Appl. No.:
11/702479
Inventors:
Theodore Hall Gasteyer - Naperville IL, US
Robert Rex Sever - Arlington Heights IL, US
Balazs Hunek - Chicago IL, US
Nigel Grinter - Buffalo Grove IL, US
Melinda Lee Verdone - Hoffman Estates IL, US
International Classification:
F25C 1/00
F26B 5/06
US Classification:
34287, 62 66
Abstract:
System and method for lyophilization or freeze-drying is provided. During the freezing step, the material or solution to be frozen is initially brought to a temperature near or below its freezing temperature after which the pressure in the freeze-dryer chamber is reduced to induce nucleation of the material.

Cognition Enhancing Compounds And Compositions, Methods Of Making, And Methods Of Treating

View page
US Patent:
20180099956, Apr 12, 2018
Filed:
Aug 18, 2017
Appl. No.:
15/680477
Inventors:
- Madison WI, US
Richard R. Copp - Oregon WI, US
James G. Farnham - Madison WI, US
Seth A. Hanson - Madison WI, US
Michael L. Hendrickson - Madison WI, US
Jeffrey C. Ockuly - Madison WI, US
Trevor M. Twose - Fitchburg WI, US
Melinda L. Verdone - Waunakee WI, US
International Classification:
C07D 413/04
C07D 403/04
C07D 417/04
C07B 59/00
Abstract:
The invention relates generally to muscarinic agonists, which are useful for stimulating muscarine receptors, and treating cognitive disorders. Included among the muscarinic agonists disclosed herein are oxadiazole derivatives, compositions, and preparations thereof. Methods of synthesizing oxadiazole compounds also are provided. This disclosure also relates in part to compositions for enhancing cognitive function in subjects such as humans, the compositions comprising a muscarinic agonist or a pharmaceutically suitable form thereof. This disclosure relates in part to methods of treating animals such as humans by administering such compositions.

Compounds And Compositions For Cognition-Enhancement, Methods Of Making, And Methods Of Treating

View page
US Patent:
20170313687, Nov 2, 2017
Filed:
Jul 18, 2017
Appl. No.:
15/653453
Inventors:
- Madison WI, US
Jeffrey C. Ockuly - Madison WI, US
Trevor M. Twose - Hayward WI, US
Melinda L. Verdone - Waunakee WI, US
Brent D. Abraham - Verona WI, US
Richard R. Copp - Oregon WI, US
James G. Farnham - Madison WI, US
Seth A. Hanson - Madison WI, US
International Classification:
C07D 413/04
A61K 9/00
A61K 31/453
A61K 31/439
A61K 31/4025
A61K 31/401
A61K 31/216
A61K 31/4725
A61K 9/48
A61K 9/28
A61K 9/20
A61K 9/20
A61K 9/20
A61K 9/00
C07D 417/04
A61K 9/70
Abstract:
Disclosed are muscarinic agonist compounds including oxadiazole derivatives, compositions and preparations thereof. Also disclosed are methods of synthesizing such oxadiazole compounds. Further disclosed are methods for treating a subject with said muscarinic agonists or a pharmaceutically suitable form thereof to enhance cognitive function.

Cognition Enhancing Compounds And Compositions, Methods Of Making, And Methods Of Treating

View page
US Patent:
20160340348, Nov 24, 2016
Filed:
Jul 29, 2016
Appl. No.:
15/224287
Inventors:
- Madison WI, US
Richard R. Copp - Oregon WI, US
James G. Farnham - Madison WI, US
Seth A. Hanson - Madison WI, US
Michael L. Hendrickson - Madison WI, US
Jeffrey C. Ockuly - Madison WI, US
Trevor M. Twose - Fitchburg WI, US
Melinda L. Verdone - Waunakee WI, US
International Classification:
C07D 413/04
C07B 59/00
Abstract:
The invention relates generally to muscarinic agonists, which are useful for stimulating muscarine receptors, and treating cognitive disorders. Included among the muscarinic agonists disclosed herein are oxadiazole derivatives, compositions, and preparations thereof. Methods of synthesizing oxadiazole compounds also are provided. This disclosure also relates in part to compositions for enhancing cognitive function in subjects such as humans, the compositions comprising a muscarinic agonist or a pharmaceutically suitable form thereof. This disclosure relates in part to methods of treating animals such as humans by administering such compositions.
Control profile
Melinda L Verdone from Monona, WI, age ~48 Get Report